These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35434848)

  • 81. New Nonalcoholic Fatty Liver Disease and Fibrosis Progression Associate With the Risk of Incident Chronic Kidney Disease.
    Zuo G; Xuan L; Xin Z; Xu Y; Lu J; Chen Y; Dai M; Zhang D; Wang W; Li M; Bi Y; Ning G; Xu M
    J Clin Endocrinol Metab; 2021 Sep; 106(10):e3957-e3968. PubMed ID: 34125886
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Association between positivity of serum autoantibodies and liver disease severity in patients with biopsy-proven NAFLD.
    Zhou YJ; Zheng KI; Ma HL; Li G; Pan XY; Zhu PW; Targher G; Byrne CD; Wang XD; Chen YP; Li XB; Zheng MH
    Nutr Metab Cardiovasc Dis; 2021 Feb; 31(2):552-560. PubMed ID: 33250371
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Frequency of Nonalcoholic Fatty Liver Disease and Subclinical Atherosclerosis Among Young Mexican Americans.
    Gill C; Vatcheva KP; Pan JJ; Smulevitz B; McPherson DD; Fallon M; McCormick JB; Fisher-Hoch SP; Laing ST
    Am J Cardiol; 2017 Jun; 119(11):1717-1722. PubMed ID: 28395890
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Association between Fasting Ketonuria and Advanced Liver Fibrosis in Non-Alcoholic Fatty Liver Disease Patients without Prediabetes and Diabetes Mellitus.
    Lim K; Kang M; Park J
    Nutrients; 2021 Sep; 13(10):. PubMed ID: 34684404
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Metabolic syndrome, non-alcoholic fatty liver disease and liver stiffness in psoriatic arthritis and psoriasis patients.
    Ortolan A; Lorenzin M; Tadiotto G; Russo FP; Oliviero F; Felicetti M; D'Incà R; Favero M; Piaserico S; Doria A; Ramonda R
    Clin Rheumatol; 2019 Oct; 38(10):2843-2850. PubMed ID: 31254236
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Fasting Ketonuria and the Risk of Incident Nonalcoholic Fatty Liver Disease With and Without Liver Fibrosis in Nondiabetic Adults.
    Kim Y; Chang Y; Kwon MJ; Hong YS; Kim MK; Sohn W; Cho YK; Shin H; Wild SH; Byrne CD; Ryu S
    Am J Gastroenterol; 2021 Nov; 116(11):2270-2278. PubMed ID: 34114568
    [TBL] [Abstract][Full Text] [Related]  

  • 87. The Presence of White Matter Lesions Is Associated With the Fibrosis Severity of Nonalcoholic Fatty Liver Disease.
    Petta S; Tuttolomondo A; Gagliardo C; Zafonte R; Brancatelli G; Cabibi D; Cammà C; Di Marco V; Galvano L; La Tona G; Licata A; Magliozzo F; Maida C; Marchesini G; Merlino G; Midiri M; Parrinello G; Torres D; Pinto A; Craxì A
    Medicine (Baltimore); 2016 Apr; 95(16):e3446. PubMed ID: 27100443
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Metabolic syndrome and severity of fibrosis in nonalcoholic fatty liver disease: An age-dependent risk profiling study.
    Petta S; Eslam M; Valenti L; Bugianesi E; Barbara M; Cammà C; Porzio M; Rosso C; Fargion S; George J; Craxì A
    Liver Int; 2017 Sep; 37(9):1389-1396. PubMed ID: 28235154
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Subclinical thyroid dysfunction and chronic kidney disease: a nationwide population-based study.
    Kim HJ; Park SJ; Park HK; Byun DW; Suh K; Yoo MH
    BMC Nephrol; 2023 Mar; 24(1):64. PubMed ID: 36949396
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Nonalcoholic fatty liver disease in patients with inflammatory bowel disease: Beyond the natural history.
    Magrì S; Paduano D; Chicco F; Cingolani A; Farris C; Delogu G; Tumbarello F; Lai M; Melis A; Casula L; Fantini MC; Usai P
    World J Gastroenterol; 2019 Oct; 25(37):5676-5686. PubMed ID: 31602167
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Serum folate associated with nonalcoholic fatty liver disease and advanced hepatic fibrosis.
    Chen HK; Luo J; Li XJ; Liao WZ; Hu YQ; Guo XG
    Sci Rep; 2023 Aug; 13(1):12933. PubMed ID: 37558738
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Association between smoking cessation and non-alcoholic fatty liver disease using NAFLD liver fat score.
    Jang YS; Joo HJ; Park YS; Park EC; Jang SI
    Front Public Health; 2023; 11():1015919. PubMed ID: 36875368
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Thyroid Stimulating Hormone Levels Are Associated With Genetically Predicted Nonalcoholic Fatty Liver Disease.
    Fan H; Liu Z; Zhang X; Wu S; Shi T; Zhang P; Xu Y; Chen X; Zhang T
    J Clin Endocrinol Metab; 2022 Aug; 107(9):2522-2529. PubMed ID: 35763044
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Association between birth weight, preterm birth, and nonalcoholic fatty liver disease in a community-based cohort.
    Amadou C; Nabi O; Serfaty L; Lacombe K; Boursier J; Mathurin P; Ribet C; de Ledinghen V; Zins M; Charles MA
    Hepatology; 2022 Nov; 76(5):1438-1451. PubMed ID: 35474232
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Nonalcoholic fatty liver disease, serum cytokines, and dementia among rural-dwelling older adults in China: A population-based study.
    Wang Y; Li Y; Liu K; Han X; Dong Y; Wang X; Wang M; Cong L; Zhang Q; Tang S; Hou T; Liu C; Song L; Han X; Vetrano DL; Du Y; Qiu C
    Eur J Neurol; 2022 Sep; 29(9):2612-2621. PubMed ID: 35608965
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Association Between Nonalcoholic Fatty Liver Disease and the Risk of Cardiovascular Disease in the Middle-Age and Elderly Population of Northern China: A Cross-Sectional Study.
    Zhang X; Wang L; Wang G; Li J; Mu Y; Wang S; Li X
    Diabetes Metab Syndr Obes; 2024; 17():3079-3085. PubMed ID: 39184552
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Association between thyroid function and nonalcoholic fatty liver disease: a dose-response meta-analysis.
    Xiang LL; Cao YT; Sun J; Li RH; Qi F; Zhang YJ; Zhang WH; Yan L; Zhou XQ
    Front Endocrinol (Lausanne); 2024; 15():1399517. PubMed ID: 38982990
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Association of Subclinical Hypothyroidism with Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study.
    Sheikhi V; Heidari Z
    Adv Biomed Res; 2022; 11():124. PubMed ID: 36798918
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Sex differences in the relationship between hepatic steatosis, mood and anxiety disorders.
    Goulart AC; Bianchi LLT; Bismarchi D; Miname MH; Lourenção ACM; Henares BB; Garcia AT; de Almeida MS; Machado TAO; Syllos DH; Rienzo M; Wang YP
    J Psychosom Res; 2023 May; 168():111216. PubMed ID: 36913766
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Impact of thyroid cancer on the cancer risk in patients with non-alcoholic fatty liver disease or dyslipidemia.
    Ho J; Kim E; Lee M; Jung I; Jo YS; Lee J
    Sci Rep; 2023 Jan; 13(1):1076. PubMed ID: 36658156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.